Revance Therapeutics, Inc. Facing Class Action Lawsuit: Johnson Fistel Reports …

Johnson Fistel, LLP has initiated a class action lawsuit for investors of Revance Therapeutics, Inc. (NASDAQ: RVNC). This legal action involves allegations related to potential securities law violations by the company.

The lawsuit focuses on Revance’s statements regarding the business, operations, and prospects of the company. Investors who purchased Revance securities between August 2, 2019, and May 28, 2021, may be included in the class action lawsuit. The lawsuit alleges that during this period, Revance made false and misleading statements about its business, which could have an impact on investors.

The allegations include claims that Revance overstated the commercial prospects and market potential of DaxibotulinumtoxinA for Injection in treating forehead lines, improperly relied on the results of the SAKURA Phase 3 trial, and failed to disclose adverse information regarding Revance’s business and prospects.

These allegations have caused harm to investors who purchased Revance securities during the specified period, and as a result, they may be eligible to participate in the class action lawsuit. It is essential for investors to review their transactions and determine whether they are affected by the alleged securities law violations.

Investors who wish to participate in the class action lawsuit against Revance should contact Johnson Fistel, LLP for more information. The law firm is committed to representing the interests of investors who have been harmed by securities law violations and will work to recover losses on behalf of affected investors.

Regarding the class action lawsuit against Revance Therapeutics, Inc. (NASDAQ: RVNC), investors should be aware of the potential implications on their investments. It is crucial for investors to understand the allegations and determine whether they are part of the class action lawsuit.

Investors who have suffered losses due to purchasing Revance securities during the specified period should take appropriate action to protect their rights and seek compensation for their losses. Johnson Fistel, LLP is available to assist investors in understanding their legal options and pursuing recovery for any damages suffered as a result of the alleged securities law violations by Revance.